Recent Study on BIA-ALCL RisksSince my last article on this topic, "What is the Risk of Death Due to Breast Implant-Associated Lymphoma?," additional information on the risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has been released. The most recent study, titled "Breast Implants and the Risk of Anaplastic Large-Cell … [Read more...]
Breast Implant-Associated Lymphoma Diagnoses on the Rise
On October 18, 2017, the JAMA Surgery journal published an article titled "Breast Implant–Associated Anaplastic Large Cell Lymphoma A Systematic Review," in which they discuss the rate of occurrence of the condition. The article served as a review of 115 articles on the topic of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) … [Read more...]
Could Beta-Blocker Use in Pregnant Women Cause Fetal Heart Defects?
On April 3, 2017, updated results from the National Birth Defects Prevention Study (NBDPS) were released and published in the article "Maternal Antihypertensive Medication Use and Congenital Heart Defects" (Abstract only). This study found that there was a statistically significant association between β-blocker use in pregnant women and fetal … [Read more...]